Chen CL - Search Results

1

Proteomic characterization of arsenic and cadmium exposure in bladder cells.

Chen YT, Ou Yang WT, Juang HH, Chen CL, Chen HW, Tsui KH, Chang YH, Tsai CH, Hsueh C, Liao WC. Chen YT, et al. Among authors: chen hw, chen cl. Rapid Commun Mass Spectrom. 2020 Apr;34 Suppl 1:e8578. doi: 10.1002/rcm.8578. Epub 2020 Feb 8. Rapid Commun Mass Spectrom. 2020. PMID: 31499585

2

Synchronous primary carcinomas of the bladder and prostate.

Lee SH, Chang PL, Chen SM, Sun GH, Chen CL, Shen BY, Wu YS, Tsui KH. Lee SH, et al. Among authors: chen cl, chen sm. Asian J Androl. 2006 May;8(3):357-9. doi: 10.1111/j.1745-7262.2006.00129.x. Asian J Androl. 2006. PMID: 16625287 Free article.

3

Comparisons of voided urine cytology, nuclear matrix protein-22 and bladder tumor associated antigen tests for bladder cancer of geriatric male patients in Taiwan, China.

Tsui KH, Chen SM, Wang TM, Juang HH, Chen CL, Sun GH, Chang PL. Tsui KH, et al. Among authors: chen cl, chen sm. Asian J Androl. 2007 Sep;9(5):711-5. doi: 10.1111/j.1745-7262.2007.00218.x. Asian J Androl. 2007. PMID: 17712491 Free article.

4

Can probability of genetic mutation be an indicator of clinical relevance?

Chen CL, Tsui KH, Lin CY, Chang PL, Tang P, Yung B. Chen CL, et al. Genomics. 2007 Dec;90(6):746-50. doi: 10.1016/j.ygeno.2007.07.006. Epub 2007 Oct 24. Genomics. 2007. PMID: 17920239 Free article.

5

Association of nucleophosmin/B23 with bladder cancer recurrence based on immunohistochemical assessment in clinical samples.

Tsui KH, Juang HH, Lee TH, Chang PL, Chen CL, Yung BY. Tsui KH, et al. Among authors: chen cl. Acta Pharmacol Sin. 2008 Mar;29(3):364-70. doi: 10.1111/j.1745-7254.2008.00747.x. Acta Pharmacol Sin. 2008. PMID: 18298902

6

Web-based clinical pathway for reducing practice variations in radical prostatectomy.

Hsu YC, Tsui KH, Chen CL, Lee SH, Wu YS, Chang PL. Hsu YC, et al. Among authors: chen cl. Chang Gung Med J. 2008 Nov-Dec;31(6):567-75. Chang Gung Med J. 2008. PMID: 19241896 Free article.

7

Risk factors associated with transrectal ultrasound guided prostate needle biopsy in patients with prostate cancer.

Lee SH, Chen SM, Ho CR, Chang PL, Chen CL, Tsui KH. Lee SH, et al. Among authors: chen cl, chen sm. Chang Gung Med J. 2009 Nov-Dec;32(6):623-7. Chang Gung Med J. 2009. PMID: 20035641 Free article.

8

Discovery of novel bladder cancer biomarkers by comparative urine proteomics using iTRAQ technology.

Chen YT, Chen CL, Chen HW, Chung T, Wu CC, Chen CD, Hsu CW, Chen MC, Tsui KH, Chang PL, Chang YS, Yu JS. Chen YT, et al. Among authors: chen cd, chen hw, chen cl, chen mc. J Proteome Res. 2010 Nov 5;9(11):5803-15. doi: 10.1021/pr100576x. Epub 2010 Sep 17. J Proteome Res. 2010. PMID: 20806971

9

A comparison of androgen deprivation therapy versus surgical castration for patients with advanced prostatic carcinoma.

Lin YH, Chen CL, Hou CP, Chang PL, Tsui KH. Lin YH, et al. Among authors: chen cl. Acta Pharmacol Sin. 2011 Apr;32(4):537-42. doi: 10.1038/aps.2010.236. Epub 2011 Mar 14. Acta Pharmacol Sin. 2011. PMID: 21399652 Free PMC article.

10

Does adequate bladder cuff excision impact outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma.

Hou CP, Chang PL, Chen CL, Lin YH, Tsui KH. Hou CP, et al. Among authors: chen cl. Chang Gung Med J. 2011 Sep-Oct;34(5):496-505. Chang Gung Med J. 2011. PMID: 22035894 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,435 results

Search Page